Application 021443
- Type
- NDA
- Sponsor
- ASPEN
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | ENJUVIA | ESTROGENS, CONJUGATED SYNTHETIC B | TABLET;ORAL | 0.3MG | No | No |
| 002 | ENJUVIA | ESTROGENS, CONJUGATED SYNTHETIC B | TABLET;ORAL | 0.45MG | No | No |
| 003 | ENJUVIA | ESTROGENS, CONJUGATED SYNTHETIC B | TABLET;ORAL | 0.625MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | No | No |
| 004 | ENJUVIA | ESTROGENS, CONJUGATED SYNTHETIC B | TABLET;ORAL | 1.25MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | No | No |
| 005 | ENJUVIA | ESTROGENS, CONJUGATED SYNTHETIC B | TABLET;ORAL | 0.9MG | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N021443-001 | ENJUVIA | ESTROGENS, CONJUGATED SYNTHETIC B | 0.3MG | TABLET / ORAL | 2004-12-20 | ||
| N021443-002 | ENJUVIA | ESTROGENS, CONJUGATED SYNTHETIC B | 0.45MG | TABLET / ORAL | 2004-12-20 | ||
| N021443-003 | ENJUVIA | ESTROGENS, CONJUGATED SYNTHETIC B | 0.625MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | 2004-05-10 | ||
| N021443-004 | ENJUVIA | ESTROGENS, CONJUGATED SYNTHETIC B | 1.25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | 2004-05-10 | ||
| N021443-005 | ENJUVIA | ESTROGENS, CONJUGATED SYNTHETIC B | 0.9MG | TABLET / ORAL | 2007-04-27 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N021443-001 | ENJUVIA | 0.3MG | TABLET / ORAL | 2004-12-20 | 87673890dc5c… | ||
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N021443-002 | ENJUVIA | 0.45MG | TABLET / ORAL | 2004-12-20 | 87673890dc5c… | ||
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N021443-003 | ENJUVIA | 0.625MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | TABLET / ORAL | 2004-05-10 | 87673890dc5c… | ||
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N021443-004 | ENJUVIA | 1.25MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | TABLET / ORAL | 2004-05-10 | 87673890dc5c… | ||
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N021443-005 | ENJUVIA | 0.9MG | TABLET / ORAL | 2007-04-27 | 87673890dc5c… | ||
| 2021-03-12 10:30 UTC | 2021-03 | N021443-001 | ENJUVIA | 0.3MG | TABLET / ORAL | 2004-12-20 | 5aa47cf7b7d7… | ||
| 2021-03-12 10:30 UTC | 2021-03 | N021443-002 | ENJUVIA | 0.45MG | TABLET / ORAL | 2004-12-20 | 5aa47cf7b7d7… | ||
| 2021-03-12 10:30 UTC | 2021-03 | N021443-003 | ENJUVIA | 0.625MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | TABLET / ORAL | 2004-05-10 | 5aa47cf7b7d7… | ||
| 2021-03-12 10:30 UTC | 2021-03 | N021443-004 | ENJUVIA | 1.25MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | TABLET / ORAL | 2004-05-10 | 5aa47cf7b7d7… | ||
| 2021-03-12 10:30 UTC | 2021-03 | N021443-005 | ENJUVIA | 0.9MG | TABLET / ORAL | 2007-04-27 | 5aa47cf7b7d7… | ||
| 2020-12-22 03:56 UTC | 2020-12 | N021443-001 | ENJUVIA | 0.3MG | TABLET / ORAL | 2004-12-20 | 8869cabd3fbd… | ||
| 2020-12-22 03:56 UTC | 2020-12 | N021443-002 | ENJUVIA | 0.45MG | TABLET / ORAL | 2004-12-20 | 8869cabd3fbd… | ||
| 2020-12-22 03:56 UTC | 2020-12 | N021443-003 | ENJUVIA | 0.625MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | TABLET / ORAL | 2004-05-10 | 8869cabd3fbd… | ||
| 2020-12-22 03:56 UTC | 2020-12 | N021443-004 | ENJUVIA | 1.25MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | TABLET / ORAL | 2004-05-10 | 8869cabd3fbd… | ||
| 2020-12-22 03:56 UTC | 2020-12 | N021443-005 | ENJUVIA | 0.9MG | TABLET / ORAL | 2007-04-27 | 8869cabd3fbd… | ||
| 2020-11-12 02:37 UTC | 2020-11 | N021443-001 | ENJUVIA | 0.3MG | TABLET / ORAL | 2004-12-20 | c0c555d07b60… | ||
| 2020-11-12 02:37 UTC | 2020-11 | N021443-002 | ENJUVIA | 0.45MG | TABLET / ORAL | 2004-12-20 | c0c555d07b60… | ||
| 2020-11-12 02:37 UTC | 2020-11 | N021443-003 | ENJUVIA | 0.625MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | TABLET / ORAL | 2004-05-10 | c0c555d07b60… | ||
| 2020-11-12 02:37 UTC | 2020-11 | N021443-004 | ENJUVIA | 1.25MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | TABLET / ORAL | 2004-05-10 | c0c555d07b60… | ||
| 2020-11-12 02:37 UTC | 2020-11 | N021443-005 | ENJUVIA | 0.9MG | TABLET / ORAL | 2007-04-27 | c0c555d07b60… | ||
| 2019-12-14 00:12 UTC | 2019-12 | N021443-001 | ENJUVIA | 0.3MG | TABLET / ORAL | 2004-12-20 | 3f01610625f2… | ||
| 2019-12-14 00:12 UTC | 2019-12 | N021443-002 | ENJUVIA | 0.45MG | TABLET / ORAL | 2004-12-20 | 3f01610625f2… | ||
| 2019-12-14 00:12 UTC | 2019-12 | N021443-003 | ENJUVIA | 0.625MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | TABLET / ORAL | 2004-05-10 | 3f01610625f2… | ||
| 2019-12-14 00:12 UTC | 2019-12 | N021443-004 | ENJUVIA | 1.25MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | TABLET / ORAL | 2004-05-10 | 3f01610625f2… | ||
| 2019-12-14 00:12 UTC | 2019-12 | N021443-005 | ENJUVIA | 0.9MG | TABLET / ORAL | 2007-04-27 | 3f01610625f2… | ||
| 2019-09-15 20:21 UTC | 2019-09 | N021443-001 | ENJUVIA | 0.3MG | TABLET / ORAL | 2004-12-20 | b00525d2431f… | ||
| 2019-09-15 20:21 UTC | 2019-09 | N021443-002 | ENJUVIA | 0.45MG | TABLET / ORAL | 2004-12-20 | b00525d2431f… | ||
| 2019-09-15 20:21 UTC | 2019-09 | N021443-003 | ENJUVIA | 0.625MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | TABLET / ORAL | 2004-05-10 | b00525d2431f… | ||
| 2019-09-15 20:21 UTC | 2019-09 | N021443-004 | ENJUVIA | 1.25MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | TABLET / ORAL | 2004-05-10 | b00525d2431f… | ||
| 2019-09-15 20:21 UTC | 2019-09 | N021443-005 | ENJUVIA | 0.9MG | TABLET / ORAL | 2007-04-27 | b00525d2431f… | ||
| 2019-07-19 19:46 UTC | 2019-07 | N021443-001 | ENJUVIA | 0.3MG | TABLET / ORAL | 2004-12-20 | ea99ee380514… | ||
| 2019-07-19 19:46 UTC | 2019-07 | N021443-002 | ENJUVIA | 0.45MG | TABLET / ORAL | 2004-12-20 | ea99ee380514… | ||
| 2019-07-19 19:46 UTC | 2019-07 | N021443-003 | ENJUVIA | 0.625MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | TABLET / ORAL | 2004-05-10 | ea99ee380514… | ||
| 2019-07-19 19:46 UTC | 2019-07 | N021443-004 | ENJUVIA | 1.25MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | TABLET / ORAL | 2004-05-10 | ea99ee380514… | ||
| 2019-07-19 19:46 UTC | 2019-07 | N021443-005 | ENJUVIA | 0.9MG | TABLET / ORAL | 2007-04-27 | ea99ee380514… | ||
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | N021443-001 | ENJUVIA | 0.3MG | TABLET / ORAL | 2004-12-20 | 6a51e52b5d6a… | ||
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | N021443-002 | ENJUVIA | 0.45MG | TABLET / ORAL | 2004-12-20 | 6a51e52b5d6a… | ||
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | N021443-003 | ENJUVIA | 0.625MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | 2004-05-10 | 6a51e52b5d6a… | ||
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | N021443-004 | ENJUVIA | 1.25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | 2004-05-10 | 6a51e52b5d6a… | ||
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | N021443-005 | ENJUVIA | 0.9MG | TABLET / ORAL | 2007-04-27 | 6a51e52b5d6a… |
Observed Orange Book patent history#
| Captured | Edition | Application-product | Patent | Expiration | Use code | Coverage / status | Submission date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|
| 2019-12-13 00:20 UTC | 2019-12 | N021443-001 | 6855703 | 2021-02-12 | U-905 | Drug substance, Drug product | 74a2ff9319b5… | |
| 2019-12-13 00:20 UTC | 2019-12 | N021443-001 | 6855703 | 2021-02-12 | U-904 | Drug substance, Drug product | 74a2ff9319b5… | |
| 2019-12-13 00:20 UTC | 2019-12 | N021443-001 | 6660726 | 2021-03-08 | U-905 | Drug substance, Drug product | 74a2ff9319b5… | |
| 2019-12-13 00:20 UTC | 2019-12 | N021443-001 | 6660726 | 2021-03-08 | U-904 | Drug substance, Drug product | 74a2ff9319b5… | |
| 2019-12-13 00:20 UTC | 2019-12 | N021443-002 | 6855703 | 2021-02-12 | U-905 | Drug substance, Drug product | 74a2ff9319b5… | |
| 2019-12-13 00:20 UTC | 2019-12 | N021443-002 | 6855703 | 2021-02-12 | U-904 | Drug substance, Drug product | 74a2ff9319b5… | |
| 2019-12-13 00:20 UTC | 2019-12 | N021443-002 | 6660726 | 2021-03-08 | U-905 | Drug substance, Drug product | 74a2ff9319b5… | |
| 2019-12-13 00:20 UTC | 2019-12 | N021443-002 | 6660726 | 2021-03-08 | U-904 | Drug substance, Drug product | 74a2ff9319b5… | |
| 2019-12-13 00:20 UTC | 2019-12 | N021443-003 | 6855703 | 2021-02-12 | U-905 | Drug substance, Drug product | 74a2ff9319b5… | |
| 2019-12-13 00:20 UTC | 2019-12 | N021443-003 | 6855703 | 2021-02-12 | U-904 | Drug substance, Drug product | 74a2ff9319b5… | |
| 2019-12-13 00:20 UTC | 2019-12 | N021443-003 | 6660726 | 2021-03-08 | U-905 | Drug substance, Drug product | 74a2ff9319b5… | |
| 2019-12-13 00:20 UTC | 2019-12 | N021443-003 | 6660726 | 2021-03-08 | U-904 | Drug substance, Drug product | 74a2ff9319b5… | |
| 2019-12-13 00:20 UTC | 2019-12 | N021443-004 | 6855703 | 2021-02-12 | U-904 | Drug substance, Drug product | 74a2ff9319b5… | |
| 2019-12-13 00:20 UTC | 2019-12 | N021443-004 | 6855703 | 2021-02-12 | U-905 | Drug substance, Drug product | 74a2ff9319b5… | |
| 2019-12-13 00:20 UTC | 2019-12 | N021443-004 | 6660726 | 2021-03-08 | U-905 | Drug substance, Drug product | 74a2ff9319b5… | |
| 2019-12-13 00:20 UTC | 2019-12 | N021443-004 | 6660726 | 2021-03-08 | U-904 | Drug substance, Drug product | 74a2ff9319b5… | |
| 2019-12-13 00:20 UTC | 2019-12 | N021443-005 | 6855703 | 2021-02-12 | U-905 | Drug substance, Drug product | 74a2ff9319b5… | |
| 2019-12-13 00:20 UTC | 2019-12 | N021443-005 | 6855703 | 2021-02-12 | U-904 | Drug substance, Drug product | 74a2ff9319b5… | |
| 2019-12-13 00:20 UTC | 2019-12 | N021443-005 | 6660726 | 2021-03-08 | U-905 | Drug substance, Drug product | 74a2ff9319b5… | |
| 2019-12-13 00:20 UTC | 2019-12 | N021443-005 | 6660726 | 2021-03-08 | U-904 | Drug substance, Drug product | 74a2ff9319b5… | |
| 2021-12-28 21:50 UTC | 2021-12 | N021443-001 | 6855703 | 2021-02-12 | U-905 | Drug substance, Drug product | 782e0a99824c… | |
| 2021-12-28 21:50 UTC | 2021-12 | N021443-001 | 6855703 | 2021-02-12 | U-904 | Drug substance, Drug product | 782e0a99824c… | |
| 2021-12-28 21:50 UTC | 2021-12 | N021443-001 | 6660726 | 2021-03-08 | U-905 | Drug substance, Drug product | 782e0a99824c… | |
| 2021-12-28 21:50 UTC | 2021-12 | N021443-001 | 6660726 | 2021-03-08 | U-904 | Drug substance, Drug product | 782e0a99824c… | |
| 2021-12-28 21:50 UTC | 2021-12 | N021443-002 | 6855703 | 2021-02-12 | U-905 | Drug substance, Drug product | 782e0a99824c… | |
| 2021-12-28 21:50 UTC | 2021-12 | N021443-002 | 6855703 | 2021-02-12 | U-904 | Drug substance, Drug product | 782e0a99824c… | |
| 2021-12-28 21:50 UTC | 2021-12 | N021443-002 | 6660726 | 2021-03-08 | U-905 | Drug substance, Drug product | 782e0a99824c… | |
| 2021-12-28 21:50 UTC | 2021-12 | N021443-002 | 6660726 | 2021-03-08 | U-904 | Drug substance, Drug product | 782e0a99824c… | |
| 2021-12-28 21:50 UTC | 2021-12 | N021443-003 | 6855703 | 2021-02-12 | U-905 | Drug substance, Drug product | 782e0a99824c… | |
| 2021-12-28 21:50 UTC | 2021-12 | N021443-003 | 6855703 | 2021-02-12 | U-904 | Drug substance, Drug product | 782e0a99824c… | |
| 2021-12-28 21:50 UTC | 2021-12 | N021443-003 | 6660726 | 2021-03-08 | U-905 | Drug substance, Drug product | 782e0a99824c… | |
| 2021-12-28 21:50 UTC | 2021-12 | N021443-003 | 6660726 | 2021-03-08 | U-904 | Drug substance, Drug product | 782e0a99824c… | |
| 2021-12-28 21:50 UTC | 2021-12 | N021443-004 | 6855703 | 2021-02-12 | U-904 | Drug substance, Drug product | 782e0a99824c… | |
| 2021-12-28 21:50 UTC | 2021-12 | N021443-004 | 6855703 | 2021-02-12 | U-905 | Drug substance, Drug product | 782e0a99824c… | |
| 2021-12-28 21:50 UTC | 2021-12 | N021443-004 | 6660726 | 2021-03-08 | U-904 | Drug substance, Drug product | 782e0a99824c… | |
| 2021-12-28 21:50 UTC | 2021-12 | N021443-004 | 6660726 | 2021-03-08 | U-905 | Drug substance, Drug product | 782e0a99824c… | |
| 2021-12-28 21:50 UTC | 2021-12 | N021443-005 | 6855703 | 2021-02-12 | U-905 | Drug substance, Drug product | 782e0a99824c… | |
| 2021-12-28 21:50 UTC | 2021-12 | N021443-005 | 6855703 | 2021-02-12 | U-904 | Drug substance, Drug product | 782e0a99824c… | |
| 2021-12-28 21:50 UTC | 2021-12 | N021443-005 | 6660726 | 2021-03-08 | U-905 | Drug substance, Drug product | 782e0a99824c… | |
| 2021-12-28 21:50 UTC | 2021-12 | N021443-005 | 6660726 | 2021-03-08 | U-904 | Drug substance, Drug product | 782e0a99824c… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Documents#
| Document | Submission type | Date |
|---|---|---|
| 85029 | SUPPL | 2026-02-12 |
| 85019 | SUPPL | 2026-02-12 |
| 77539 | SUPPL | 2024-02-16 |
| 77523 | SUPPL | 2024-02-16 |
| 65472 | SUPPL | 2020-12-02 |
| 65471 | SUPPL | 2020-12-02 |
| 65447 | SUPPL | 2020-12-01 |
| 65446 | SUPPL | 2020-12-01 |
| 50271 | SUPPL | 2017-11-02 |
| 27793 | SUPPL | 2015-07-09 |
| 36936 | SUPPL | 2015-07-01 |
| 27792 | SUPPL | 2007-05-01 |
| 27791 | SUPPL | 2007-05-01 |
| 15475 | SUPPL | 2007-04-25 |
| 42168 | ORIG | 2006-07-27 |
| 27790 | ORIG | 2004-05-26 |
| 15474 | ORIG | 2004-05-19 |